Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Padró

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Thrombosis Research|March 15, 1988
Hyperlipemia, fibrinolysis and arteriosclerosisT Padró, C A Villaverde, M Cánovas
Journal of Thrombosis and Haemostasis : JTH|August 22, 2012
Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cellR Lugano, E Peña, L Badimon, et al.
Atmospheric Environment (Oxford, England : 1994)|August 25, 2021
Particle number emission factors for an urban highway tunnelJessica L Perkins, Luz T Padró-Martínez, John L Durant
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1993
Experimental hypothyroidism increases plasminogen activator inhibitor activity in rat plasmaT Padró, C M van den Hoogen, J J Emeis
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1990
Distribution of tissue-type plasminogen activator (activity and antigen) in rat tissuesT Padró, C M van den Hoogen, J J Emeis
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1991
Plasmin inhibitory effect of rat tissues: comparison with antiplasmin activity of plasmaT Padró, C M van den Hoogen, J J Emeis
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1983
Hypolipemic profile of plafibride in a model of experimental atherosclerosisJ J Badimón, T Padró, M Cánovas, et al.
Current Molecular Medicine|August 22, 2006
Cell biology and lipoproteins in atherosclerosisL Badimon, J Martínez-González, V Llorente-Cortés, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic diseaseT Padró, J J Emeis, M Steins, et al.
Neurological Research|December 22, 1999
Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiologyP Zunker, A Schick, T Padró, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Thrombosis Research|March 15, 1988
Hyperlipemia, fibrinolysis and arteriosclerosisT Padró, C A Villaverde, M Cánovas
Journal of Thrombosis and Haemostasis : JTH|August 22, 2012
Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cellR Lugano, E Peña, L Badimon, et al.
Atmospheric Environment (Oxford, England : 1994)|August 25, 2021
Particle number emission factors for an urban highway tunnelJessica L Perkins, Luz T Padró-Martínez, John L Durant
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1993
Experimental hypothyroidism increases plasminogen activator inhibitor activity in rat plasmaT Padró, C M van den Hoogen, J J Emeis
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1990
Distribution of tissue-type plasminogen activator (activity and antigen) in rat tissuesT Padró, C M van den Hoogen, J J Emeis
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1991
Plasmin inhibitory effect of rat tissues: comparison with antiplasmin activity of plasmaT Padró, C M van den Hoogen, J J Emeis
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1983
Hypolipemic profile of plafibride in a model of experimental atherosclerosisJ J Badimón, T Padró, M Cánovas, et al.
Current Molecular Medicine|August 22, 2006
Cell biology and lipoproteins in atherosclerosisL Badimon, J Martínez-González, V Llorente-Cortés, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic diseaseT Padró, J J Emeis, M Steins, et al.
Neurological Research|December 22, 1999
Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiologyP Zunker, A Schick, T Padró, et al.
Pageof 4